<DOC>
	<DOCNO>NCT01427374</DOCNO>
	<brief_summary>Individuals kidney disease high risk heart vascular disease , include heart attack stroke , normal kidney function . The purpose research study collect information cause , complication treatment kidney disease . Patient characteristic , comorbid disease laboratory marker use routine practice , well novel biochemical marker genetic data collect examine relationship biochemical genetic marker cardiovascular risk . Information health history incident hemodialysis peritoneal dialysis patient capture use structure patient interview review medical record . Blood urine specimen collect time dialysis initiation store order perform novel biochemical genetic assay future . The overall goal CKDCS/LUCID study improve understand cardiac-associated risk improve treatment patient kidney disease . A cardiac imaging substudy perform subset patient enrol . The goal substudy examine whether risk develop common cardiac-related complication ( coronary artery calcification [ CAC ] leave ventricular hypertrophy [ LVH ] ) associate certain medication take individual dialysis whether risk modify genotypic predisposition .</brief_summary>
	<brief_title>Risk Factors Coronary Artery Calcification Left Ventricular Hypertrophy Hemodialysis Patients</brief_title>
	<detailed_description>This study conduct Sponsorship University Alberta ( Edmonton , Alberta , Canada ) fund Canadian Institutes Health Industry Partnered Research Grant IRO 90262 - partnership funding Abbott Laboratories . The co-Principal Investigators Marcello Tonelli MD SM Ravi Thadhani , MD , MPH . A total 750 patient anticipate enrol Massachusetts General Hospital ( MGH ) . The remain patient enrol Canada . This study utilize data `` The Canadian Kidney Disease Cohort Study '' ( CKDCS ) `` The Longitudinal US/Canada Incident Dialysis STUDY ( LUCID ) .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Calcinosis</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Adults ( ≥ 18 year age ) commence hemodialysis peritoneal dialysis . • Unable provide inform consent . Exclusion Criteria cardiac substudy : CT exclusion criterion 1 . Pregnancy 2 . Obesity ( &gt; 275 lb ) 3 . Rapid atrial fibrillation , bigeminy trigeminy 4 . Any condition impedes ability lie flat CT ( eg : decompensated congestive heart failure ) . MRI exclusion criterion 1 . Cardiac pacemaker implantable defibrillator 2 . Obesity ( &gt; 275lbs ) 3 . Intraocular metal 4 . Cerebral aneurysm clip , programmable shunt , etc . 5 . Any type ear implant 6 . Any implanted device ( eg : insulin , drug infusion device ) 7 . Metal shrapnel bullet 8 . Any condition impedes ability lie flat MRI ( eg : decompensated congestive heart failure )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>hemodialysis</keyword>
	<keyword>peritoneal dialysis</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>cardiovascular risk factor</keyword>
	<keyword>cardiac imaging</keyword>
	<keyword>dialysis</keyword>
	<keyword>parathyroid hormone</keyword>
	<keyword>vitamin D</keyword>
	<keyword>coronary artery calcification</keyword>
	<keyword>leave ventricular hypertrophy</keyword>
	<keyword>genetic predisposition</keyword>
	<keyword>biochemical marker</keyword>
	<keyword>infection</keyword>
	<keyword>pharmacogenomics</keyword>
</DOC>